UTIMES(SH:688638)2025-04-28 13:40Financial Performance - The company's revenue for Q1 2025 was ¥95,604,339.21, a decrease of 27.09% compared to ¥131,124,420.61 in the same period last year[3] - The net profit attributable to shareholders was -¥45,876,715.83, representing a decline of 150.39% from -¥18,322,447.98 year-over-year[3] - Net loss for Q1 2025 was CNY 44,372,766.04, compared to a net loss of CNY 18,328,012.87 in Q1 2024, indicating a significant increase in losses[17] - Operating profit for Q1 2025 was CNY -33,914,819.08, worsening from CNY -23,383,459.49 in Q1 2024[17] - The gross profit margin for Q1 2025 was negative, with a gross loss of CNY 2,608,995.00, compared to a gross profit in the previous year[26] - The net profit for the company in the latest quarter was CNY -36,342,434.22, worsening from CNY -14,615,331.17 in the same quarter last year[27] Cash Flow - The net cash flow from operating activities improved to ¥27,104,400.56, a significant increase of 125.91% compared to -¥104,612,172.92 in the previous year[3] - Cash flow from operating activities in Q1 2025 was CNY 212,474,786.83, a substantial increase from CNY 33,739,265.18 in Q1 2024[20] - The net cash flow from operating activities was CNY 27,104,400.56, a significant improvement compared to a net outflow of CNY 104,612,172.92 in the previous period[21] - In Q1 2025, the company reported a net cash outflow from operating activities of CNY -47,942,439.44, an improvement from CNY -156,902,599.88 in Q1 2024[28] - The company's total operating cash outflow was CNY 172,258,990.10 in Q1 2025, a decrease from CNY 195,853,896.02 in Q1 2024[28] Assets and Liabilities - Total assets increased by 11.07% to ¥2,400,838,619.36 from ¥2,161,629,947.73 at the end of the previous year[4] - Total liabilities increased to CNY 1,426,787,024.87 from CNY 1,139,144,067.91, marking a rise of 25.3%[14] - The company's equity attributable to shareholders decreased to CNY 920,156,662.04 from CNY 971,048,137.19, a decline of 5.2%[14] - The company's total liabilities increased to CNY 1,148,416,993.96 from CNY 922,410,690.89, reflecting a rise of 24.5%[25] - The company's equity decreased to CNY 963,907,739.96 from CNY 1,005,269,793.55, indicating a decline of 4.1%[25] Research and Development - Research and development expenses totaled ¥17,568,326.91, up 27.66% from ¥13,761,693.61, accounting for 18.38% of total revenue, an increase of 7.88 percentage points[4] - Research and development expenses for Q1 2025 were CNY 17,568,326.91, up from CNY 13,761,693.61 in Q1 2024, representing a 27.0% increase[17] - Research and development expenses for Q1 2025 were CNY 9,329,227.63, down from CNY 12,205,675.03 in Q1 2024, indicating a 23.5% reduction[26] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 4,436, with no preferred shareholders restoring voting rights[7] - The company reported a total of 8,757,714 shares held by major shareholder Song Chunxiang, representing 15.64% of total shares[8] - The company has no significant changes in the participation of major shareholders in margin trading and securities lending activities[9] Other Information - The company reported non-recurring gains of ¥2,628,366.47, primarily from government subsidies and other non-operating income[6] - The company has not reported any significant new product developments or technological advancements during the reporting period[10] - There are no significant mergers or acquisitions reported in the current financial period[10] - The company has not provided specific future guidance or outlook in the current report[10]